|

Atezolizumab 1200 mg in 20 ML Injection Clinical Trials

2 actively recruiting trials

Also known as: Tecentriq

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Gruppo Oncologico Italiano di Ricerca Clinica1
  • German Cancer Research Center1

Indications

  • Cancer2
  • Mesotheliomas Pleural1
  • Early-stage Breast Cancer1
  • Lung Cancer1
  • Breast Cancer1

Other2 trials

Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso)
Phase 3
Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.